Skip to main content
. 2021 Feb 25;11:4691. doi: 10.1038/s41598-021-83913-7

Figure 4.

Figure 4

Kaplan–Meier curves demonstrating improvements in OS or DFS in TCGA TNBC patients with high quantities of CD8 T cells or CD4 memory activated T cells in their tumor sample, respectively. (a) TCGA TNBC patients with a higher proportion of CD8 T cells in their tumor have a better OS (p = 0.013, FDR = 0.24, log rank test) (survival rates high vs. low, 5 year: 96.4% and 71.9%, 10 year: 96.4% and 53.9%). (b) TCGA TNBC patients with a higher proportion of CD4 memory activated T cells in their tumor sample have a better DFS (p = 0.034, FDR = 0.66, log rank test) (survival rates high vs. low, 5 year: 85.9% and 58.2%, 10 year: 57.3% and 58.2%). (a) and (b) High and low cut offs of T cell infiltrate were chosen as quantities above and below 0.25 times the standard deviation of the mean, respectively. (a) and (b) Images generated with R 4.0.2 (https://www.R-project.org)35.